Full-Time

QC Analyst II

Posted on 1/15/2025

Zoetis

Zoetis

5,001-10,000 employees

No salary listed

Junior, Mid

Kalamazoo, MI, USA

Category
Diagnostics & Laboratory Professionals
Medical, Clinical & Veterinary
Required Skills
SAP Products
Requirements
  • AAS, BA/BS, or MS in Chemistry, Biochemistry, or related science preferred
  • Related experience in Quality Control is preferred but not required
  • Preferred experience includes GMP documentation, drug product formulation, in-plant laboratory, Incoming Inspection, SAP, LIMS, HPLC, Dissolution, use of Empower3
  • Candidate must not be Cephalosporin/Penicillin sensitive
Responsibilities
  • Performs, documents and record checks qualitative and quantitative assays on samples
  • Interprets and evaluates data for accuracy, precision, trends, and potential GMP impact
  • Recommends and executes process improvements to continually improve laboratory performance
  • Demonstrates flexibility/agility and engagement in a changing environment
  • May train others as skills and knowledge allow
  • Troubleshoot instrumentation as skills and knowledge allow
  • Participates in laboratory investigations as required
  • May participate in manufacturing QC support such as cleaning verification
Desired Qualifications
  • Related experience in Quality Control is preferred but not required
  • Key characteristics of a successful candidate in this position: willingness and ability to learn, ability to work in a team environment, and attention to detail

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Parsippany-Troy Hills, New Jersey

Founded

1952

Simplify Jobs

Simplify's Take

What believers are saying

  • Zoetis' focus on precision livestock farming aligns with AI-driven cattle health monitoring.
  • The development of mRNA vaccines complements Zoetis' existing vaccine portfolio, boosting innovation.
  • Sustainability trends in animal agriculture present opportunities for Zoetis to develop new health products.

What critics are saying

  • Emerging biotech firms like Elanco could impact Zoetis' market share in animal health.
  • Regulatory changes on antibiotic use in livestock may affect Zoetis' product offerings.
  • Volatility in raw material prices could increase production costs for Zoetis.

What makes Zoetis unique

  • Zoetis leads in animal health with a strong vaccine portfolio since its Pfizer spinoff.
  • The company is expanding digital health offerings, aligning with telemedicine trends in veterinary care.
  • Zoetis is exploring blockchain for supply chain management, enhancing product traceability and safety.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Hybrid Work Options

Company News

PYMNTS
Apr 17th, 2025
How To Manage Risks When Employees Use Ai Secretly For Work

Employees who use generative artificial intelligence tools in the workplace without company approval or oversight — a practice known as “bring your own AI’ or BYOAI — could introduce risks into the enterprise, according to MIT researchers. “Make no mistake, I’m not talking theory here,” said Nick van der Meulen, a research scientist at MIT’s [] The post How to Manage Risks When Employees Use AI Secretly for Work appeared first on PYMNTS.com.

MarketBeat
Mar 11th, 2025
Clare Market Investments LLC Makes New $670,000 Investment in Zoetis Inc. (NYSE:ZTS)

Clare Market Investments LLC makes new $670,000 investment in Zoetis Inc. (NYSE:ZTS).

MarketBeat
Mar 10th, 2025
Raymond James Financial Inc. Makes New $196.65 Million Investment in Zoetis Inc. (NYSE:ZTS)

Raymond James Financial Inc. makes new $196.65 million investment in Zoetis Inc. (NYSE:ZTS).

MarketBeat
Feb 27th, 2025
World Equity Group Inc. Invests $342,000 in Zoetis Inc. (NYSE:ZTS)

World Equity Group Inc. invests $342,000 in Zoetis Inc. (NYSE:ZTS).

MarketBeat
Feb 22nd, 2025
Tandem Investment Advisors Inc. Invests $32.19 Million in Zoetis Inc. (NYSE:ZTS)

Tandem Investment Advisors Inc. invests $32.19 million in Zoetis Inc. (NYSE:ZTS).

INACTIVE